NCT00772590View on ClinicalTrials.gov

Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

June 30, 2011

Conditions
HIV Infections
Interventions
DRUG

Raltegravir

Tablets, 400mg, twice daily

DRUG

Hyper-immune Bovine Colostrum

Tablet, 1800mg, twice daily

OTHER

raltegravir placebo

One tablet, twice daily

OTHER

Hyper-immune Bovine Colostrum placebo

Three tablets twice daily

DRUG

raltegravir and hyper-immune bovine colostrum

400mg twice daily raltegravir and 1800mg twice daily of hyper-immune bovine colostrum

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
lead

Kirby Institute

OTHER_GOV